2,575
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Xiaoyaosan, a traditional Chinese medicine, inhibits the chronic restraint stress-induced liver metastasis of colon cancer in vivo

, , , &
Pages 1094-1100 | Received 19 Apr 2020, Accepted 16 Oct 2020, Published online: 05 Nov 2020

Figures & data

Table 1. The contents of each crude medicinal component in 10 g granulated XYS.

Table 2. Sequences of the primers used in the real-time PCR analysis.

Figure 1. Effect of chronic stress and XYS on liver metastasis in a CRC model. (a) Representative images of the metastatic liver taken on day 28 after tumour cell injection. (b) Representative images of the spleen taken on day 28 after tumour cell injection. (c) Data represent average liver (left) and spleen (right) weights for the four groups. *p< 0.05, ***p< 0.001. BC: blank-control; BS: blank-stress; XC: XYS-control; XS: XYS-stress.

Figure 1. Effect of chronic stress and XYS on liver metastasis in a CRC model. (a) Representative images of the metastatic liver taken on day 28 after tumour cell injection. (b) Representative images of the spleen taken on day 28 after tumour cell injection. (c) Data represent average liver (left) and spleen (right) weights for the four groups. *p< 0.05, ***p< 0.001. BC: blank-control; BS: blank-stress; XC: XYS-control; XS: XYS-stress.

Figure 2. Effects of chronic restraint stress and XYS on the tumour microenvironment. (a) CD11b+F4/80+ cells were quantified by flow cytometry in disaggregated HT-29 primary spleen tumour harvested 28 days after cell injection. (b) Data represent the average CD11b+F4/80+ composition. (c) CD11b+GrloLy6Chi and CD11b+GrhiLy6Clo cells were quantified by flow cytometry in disaggregated HT-29 primary spleen tumour harvested 28 days after cell injection. (d) Data represent the average CD11b+GrloLy6Chi composition. *p< 0.05, **p< 0.01 and ***p< 0.001. BC: blank-control; BS: blank-stress; XC: XYS-control; XS: XYS-stress.

Figure 2. Effects of chronic restraint stress and XYS on the tumour microenvironment. (a) CD11b+F4/80+ cells were quantified by flow cytometry in disaggregated HT-29 primary spleen tumour harvested 28 days after cell injection. (b) Data represent the average CD11b+F4/80+ composition. (c) CD11b+GrloLy6Chi and CD11b+GrhiLy6Clo cells were quantified by flow cytometry in disaggregated HT-29 primary spleen tumour harvested 28 days after cell injection. (d) Data represent the average CD11b+GrloLy6Chi composition. *p< 0.05, **p< 0.01 and ***p< 0.001. BC: blank-control; BS: blank-stress; XC: XYS-control; XS: XYS-stress.

Figure 3. Effects of chronic restraint stress and XYS on liver metastasis in a CRC model. (a) mRNA expression of TGF-β, IL-6, MMP-9 and VEGF in spleen tumours relative to mice in the BC group. (b) Protein expression of TGF-β, IL-6, MMP-9 and VEGF in spleen tumours. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as a loading control. (c) Relative protein expression levels. GAPDH was used as an internal standard. (d) Immunohistochemical detection of VEGF protein expression in metastatic liver tumour tissue. (e) Immunohistochemical detection of CD31 protein expression in metastatic liver tumour tissue (magnification ×200). (f) IHC positive rate of VEGF and CD31 in metastatic liver tumours (magnification ×200). *p< 0.05, **p< 0.01 and ***p< 0.001. BC: blank-control; BS: blank-stress; XC: XYS-control; XS: XYS-stress.

Figure 3. Effects of chronic restraint stress and XYS on liver metastasis in a CRC model. (a) mRNA expression of TGF-β, IL-6, MMP-9 and VEGF in spleen tumours relative to mice in the BC group. (b) Protein expression of TGF-β, IL-6, MMP-9 and VEGF in spleen tumours. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as a loading control. (c) Relative protein expression levels. GAPDH was used as an internal standard. (d) Immunohistochemical detection of VEGF protein expression in metastatic liver tumour tissue. (e) Immunohistochemical detection of CD31 protein expression in metastatic liver tumour tissue (magnification ×200). (f) IHC positive rate of VEGF and CD31 in metastatic liver tumours (magnification ×200). *p< 0.05, **p< 0.01 and ***p< 0.001. BC: blank-control; BS: blank-stress; XC: XYS-control; XS: XYS-stress.